Form 4: Arcellx Director Kristin Myers Acquires Stock Options

Director Kristin Myers acquired stock options for 16,829 shares of Arcellx, Inc. on March 18, 2025.

Summary

• Kristin Myers, a director of Arcellx, Inc., filed a Form 4 disclosing a transaction involving derivative securities.
• On March 18, 2025, Myers acquired stock options for 16,829 shares of Arcellx common stock at an exercise price of $69.87.
• The options vest over three years from the equity grant date of March 18, 2025, with one-third vesting each year, contingent upon continued service as a Service Provider.
• Following the transaction, Myers directly owns 16,829 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options to a director is a common practice and generally viewed as a positive sign, indicating confidence in the company's future.

Positives

• The acquisition of stock options by a director signals confidence in the company's future performance.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• The granting of stock options can positively impact shareholders by aligning management's interests with the company's long-term success.
• Employees may view the granting of stock options to a director as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Arcellx, Director, Stock Options, Form 4, Equity, Beneficial Ownership, Securities